Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Emory University
Children's Oncology Group
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
National Institutes of Health Clinical Center (CC)